Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

Technology | Angiography

September 17, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Artis icono, a high-precision family of ...

Home September 17, 2019
Home
Videos | Chronic Total Occlusion (CTO)

A discussion with Khaldoon Alaswad, M.D., director, cardiac catheterization lab, Henry Ford Hospital, on treating ...

Home September 28, 2019
Home
Technology | Atherectomy Devices

September 13, 2019 — Rex Medical L.P. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

Home September 13, 2019
Home
News | Heart Failure

September 12, 2019 — Corvia Medical has sponsored and is actively enrolling patients in a heart failure (HF) device ...

Home September 12, 2019
Home
Technology | CT Angiography (CTA)

September 12, 2019 — HeartFlow Inc. has obtained clearance from the U.S. Food and Drug Administration (FDA) for the ...

Home September 12, 2019
Home
Videos | Hemodynamic Support Devices

A discussion with William O'Neill, M.D., director of the structural heart program, Henry Ford Hospital, and Michele ...

Home September 12, 2019
Home
News | Heart Valve Technology

September 11, 2019 — Percutaneous reduction of secondary mitral regurgitation in patients with heart failure does not ...

Home September 11, 2019
Home
News | Cath Lab

September 10, 2019 — An international randomized trial has shown that complete revascularization reduces major ...

Home September 10, 2019
Home
The cath lab staff UH Portage Medical Center.
Feature | Cath Lab | Anjan Gupta, M.D., FACC, FSCAI

Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute ST-segment elevation myocardial ...

Home September 09, 2019
Home
News | Stents Drug Eluting

September 5, 2019 — Biotronik's ultrathin Orsiro stent demonstrated superiority over Xience with respect to target ...

Home September 05, 2019
Home
News | Heart Valve Technology

September 5, 2019 — Abbott announced the launch of the company's TRILUMINATE Pivotal trial evaluating the safety and ...

Home September 05, 2019
Home
News | Cath Lab

September 3, 2019 — Shockwave Medical Inc. has received Breakthrough Device Designation from the U.S. Food and Drug ...

Home September 03, 2019
Home
News | Robotic Systems

September 3, 2019 — Corindus Vascular Robotics Inc. announced that EClinicalMedicine, a clinical journal published by Th ...

Home September 03, 2019
Home
Technology | Vascular Access

September 3, 2019 — New Zealand-based Adept Medical announced the launch of the Antegrade IR Platform. Clinically driven ...

Home September 03, 2019
Home
The most popular cardiac technology news in August 2019 was the FDA clearance for a new indication for both the Edwards Sapien 3 and Medtronic CoreValve transcatheter aortic valve replacement (TAVR) devices for low-risk patients. This puts the technology on equal footing with the previous standard-of-care of open heart surgery, representing a paradigm shift in cardiology.
Feature | Dave Fornell, Editor

September 3, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home September 03, 2019
Home
Subscribe Now